PHILADELPHIA, PA / ACCESSWIRE / August 14, 2019 / Kaskela Law LLC announces that it is investigating Eidos Therapeutics, Inc. (“Eidos” or the “Company”) (NASDAQ:EIDX) on behalf of the Company’s shareholders.
The investigation seeks to determine whether Eidos’ executive officers and directors violated the securities laws and/or breached their fiduciary duties, and whether shareholders have been harmed as a result of such actions.
Eidos shareholders are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.) at (484) 258 - 1585 or (888) 715 - 1740, or by email at [email protected], to discuss this investigation and their legal rights and options. Additional information may also be found at http://kaskelalaw.com/case/eidos-thera/.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
D. Seamus Kaskela, Esq.
KASKELA LAW LLC
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(484) 258 - 1585
(888) 715 - 1740
www.kaskelalaw.com
[email protected]
This notice may constitute attorney advertising in certain jurisdictions.
SOURCE: Kaskela Law LLC